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Persistence of Pre-Diabetes in Overweight and Obese
Hispanic Children
Association With Progressive Insulin Resistance, Poor
-Cell Function, and Increasing Visceral Fat
Michael I. Goran, Christianne Lane, Claudia Toledo-Corral, and Marc J. Weigensberg
OBJECTIVE—To examine changes in risk factors in overweight
and obese Hispanic children at high risk of developing type 2
diabetes.
RESEARCH DESIGN AND METHODS—We recruited 128
overweight/obese Hispanic children with a family history of type 2
diabetes primarily from clinics in East Los Angeles. Children were
evaluated annually for 4 years with an oral glucose tolerance test,
applying American Diabetes Association criteria to deﬁne diabetes
and pre-diabetes. Insulin sensitivity (Si), acute insulin response
(AIR) to glucose, and -cell function (BCF) were determined from
frequently sampled intravenous glucose tolerance tests, and total
body fat by dual-energy X-ray absorptiometry and intra-abdominal
and subcutaneous abdominal adipose tissue (IAAT and SAAT) by
magnetic resonance imaging were assessed in years 1, 2, and 4.
RESULTS—No subjects developed type 2 diabetes, 40% never
had pre-diabetes, 47% had intermittent pre-diabetes with no clear
pattern over time, and 13% had persistent pre-diabetes. At
baseline, those with persistent pre-diabetes had lower BCF and
higher IAAT. In repeated measures, Si deteriorated regardless of
pre-diabetes, and there was a signiﬁcant effect of pre-diabetes on
AIR (42% lower in pre-diabetes; P  0.01) and disposition index
(34% lower in pre-diabetes; P  0.021) and a signiﬁcant interac-
tion of pre-diabetes and time on IAAT (greater increase over time
in those with pre-diabetes; P  0.034).
CONCLUSIONS—In this group of Hispanic children at high risk
of type 2 diabetes, 1) pre-diabetes is highly variable from year to
year; 2) the prevalence of persistent pre-diabetes over 3 years is
13%; and 3) children with persistent pre-diabetes have lower
BCF, due to a lower AIR, and increasing visceral fat over time.
Diabetes 57:3007–3012, 2008
T
here are more than 35 million people of Hispanic
origin in the U.S. today, totaling 12.5% of the
population, making them the largest and fastest
growing minority group. The disproportionate
burden of obesity and its related comorbidities in Hispan-
ics, especially type 2 diabetes, is evident early in life. For
example, the lifetime risk of developing diabetes is highest
among Hispanics, with a lifetime risk of 50% for children
born in the year 2000 (1). Also, in 2000, 43.8% of Hispanics
ages 12–19 years were overweight, and 23.4% were obese;
these values were approximately double that of non-
Hispanic whites (2). Hispanic children are more insulin
resistant than Caucasian children, independent of body fat
content (3). Despite these alarming observations and
substantial health risks, there is a paucity of information
on the physiological and metabolic causes of the develop-
ment of type 2 diabetes in this high-risk population.
Increased obesity is a major determinant of insulin
resistance, but studies in adults have shown that insulin
resistance alone is insufﬁcient to cause type 2 diabetes.
Rather, the progression to type 2 diabetes has been shown
to be a combination of insulin resistance and the inability
of -cells to adequately compensate through an increase in
insulin secretion (4–7). As proposed by Bergman et al. (8)
and others (6,9), -cell compensation can be determined
by the disposition index, deﬁned as the product of insulin
secretion and insulin sensitivity (Si). Poor -cell function
(BCF), indicated by low disposition index, is predictive of
the development of type 2 diabetes in Pima Indians (9,10),
in young Hispanic women who experienced gestational
diabetes mellitus (GDM) (11,12), in Mexican-American
adults (13), and in pre-diabetic African American adults
(14).
Numerous studies in overweight and obese children and
adolescents have documented the high prevalence of
pre-diabetes, as indicated by either high fasting glucose or
impaired glucose tolerance (15–17). In our recent reports
from ongoing studies among overweight and obese His-
panic children with a family history of type 2 diabetes, we
found a cross-sectional prevalence of pre-diabetes of 32%
(15,18). In these prior cross-sectional studies, impaired
glucose tolerance and impaired fasting glucose were asso-
ciated with 16% lower BCF, but there were no differ-
ences in insulin resistance, body composition, or fat
distribution. Most prior reports examining pre-diabetes in
overweight and obese children have looked at a cross-
sectional sample with one-time assessment of glucose
tolerance as a measure of pre-diabetes. These studies are
limited by the poor test-retest reliability of the oral glucose
tolerance test (OGTT) for assessing pre-diabetes and the
likelihood of physiological variation and ﬂuctuations over
time in glucose tolerance status. In the current study, we
aimed to extend and validate prior cross-sectional ﬁndings
with a longitudinal design over 4 years in which we
evaluated glucose tolerance, Si, BCF, body fat, and visceral
fat on an annual basis. Using this approach, we were able
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pre-diabetes over 4 consecutive years as never, intermit-
tent, or persistent. This strategy enabled us to therefore
identify with greater conﬁdence those children with pre-
diabetes (i.e., those with persistent pre-diabetes). Using
this rigorous longitudinal design and robust deﬁnition of
pre-diabetes, we aimed to extend our understanding of the
natural history of the progression of type 2 diabetes risk
factors in overweight and obese Hispanics by examination
of the temporal patterns of changes in diabetes risk factors
over time.
RESEARCH DESIGN AND METHODS
We examined longitudinal data from 128 overweight and obese Hispanic
children (68 boys and 58 girls; 11.1  1.8 years old at initial visit) from the
University of Southern California Study Of Latinos At Risk (SOLAR) Diabetes
Project. These children had an average BMI at initial visit of 28.5  5.4 kg/m
2
(equivalent to a BMI percentile of 97.2  3.3). The children were recruited
from the community surrounding Los Angeles County Hospital in East Los
Angeles. The majority of children (80%) were recruited from overweight
children who were referred to various pediatric clinics for evaluation, and the
remainder were recruited by word-of-mouth (i.e., contacts obtained from
children already in the study) and local advertising. The main inclusion
criteria were a BMI 85th percentile for age and sex, a family history of type
2 diabetes (at least one parent or grandparent), and being of Hispanic ethnicity
as deﬁned by all four grandparents reporting to be Hispanic. Approximately
90% of the children were from Mexico with the remainder from Central
America. The cohort was not therefore representative of the population at
large but rather selected to represent the characteristics of a very high–risk
subgroup of the population. The 128 children were selected from the larger
cohort of 220 children on the basis of having completed four consecutive
annual screening visits to assess diabetes risk with an OGTT. The children
included in the current longitudinal analysis were comparable with others in
the cohort who were not included in the analysis. The only signiﬁcant
difference observed was a lower fasting glucose in those included in the
longitudinal analysis (92.4  6.3 vs. 94.1  6.3 mg/dl; P  0.036). There were
no signiﬁcant differences for age, sex, Tanner stage, BMI (percentile and Z
score), total body fat and lean mass, intra-abdominal and subcutaneous
abdominal adipose tissue (IAAT and SAAT, respectively), fasting insulin, Si,
acute insulin response (AIR), and disposition index. The subsample of the 128
children had complete assessments for Si, AIR, and disposition index by an
intravenous glucose tolerance test, body composition by dual-energy X-ray
absorptiometry (DEXA), and abdominal fat distribution by magnetic reso-
nance imaging (MRI) at years 1, 2, and 4. Because of budgetary cuts, these
measures were not obtained in most subjects at year 3.
The methods and study protocol have been previously outlined in detail
(15). A complete medical history and physical examination was conducted by
a licensed pediatric health care provider, which included Tanner staging using
established guidelines. Height (by a wall-mounted stadiometer) and weight
(by a balance beam medical scale) were recorded at each visit to the nearest
0.1 cm and 0.1 kg, respectively, and the average of the two measurements was
used for analysis. BMI and BMI percentiles for age and sex were determined
based on established Centers for Disease Control normative curves using
EpiInfo 2000, version 1.1. A 2-h OGTT was conducted using a dose of 1.75 g
glucose/kg body wt (maximum 75 g) as previously described (15). Using
American Diabetes Association criteria (19), pre-diabetes was deﬁned as the
presence of either impaired fasting glucose (IFG) or impaired glucose
tolerance (IGT). IFG was deﬁned as fasting glucose value 100 mg/dl, and IGT
was deﬁned as a 2-h glucose value 140 mg/dl.
On a second in-patient visit, a frequently sampled intravenous glucose
tolerance test was performed in the morning after an overnight fast as
previously described (15). A whole-body DEXA scan was performed to
determine whole-body composition using a Hologic QDR 4500W. Central fat
distribution was measured by MRI at the LAC/USC Imaging Science Center
using a GE 1.5 Signa LX-Ecospeed with a GE 1.5-Tesla magnet and a single
slice at the level of the umbilicus. This procedure measures IAAT and SAAT.
Statistical analysis. For the evaluation of patterns of pre-diabetes across
time, prevalence (percentage of total cases) at each of the four visits was
calculated. Examination of the patterns of pre-diabetes over time led to
classiﬁcation of participants into three groups, as follows. Group 1: never,
deﬁned by a negative test for pre-diabetes at all four visits; group 2:
intermittent, deﬁned by one or two positive tests for pre-diabetes from the
four annual visits; and group 3: persistent, deﬁned by three or four positive
tests for pre-diabetes at the four annual visits.
Comparisons of participant characteristics between these three groups at
baseline were performed using ANOVA and 
2 tests. The pattern of change in
key outcome variables (Si, AIR to glucose, disposition index, fasting and 2-h
glucose and insulin, whole-body fat, and visceral and subcutaneous abdominal
fat) over time in these three groups was examined using repeated-measures
ANOVA. In this analysis, the dependent variable was the outcome variable of
interest measured at visits 1, 2, and 4. Persistent pre-diabetes status over 4
years (coded as 1, 2, or 3) was the class variable, and the following were
included as covariates: sex, baseline age, body fat mass, and Tanner stage at
each of the measurement times. In addition, binomial logistic regression
analysis was used to identify risk factors at baseline predictive of those who
would have persistent pre-diabetes over 4 years. All analyses were performed
using SPSS version 11.0 (SPSS, Chicago, IL), with a type I error set with 
0.05.
RESULTS
Annual OGTTs were completed over 4 consecutive years
on 128 children. The prevalence of IGT at each of the
annual visits ranged from 20.3 to 22.7%, and the pattern of
IGT and IFG over the 4 years is shown in Table 1. Table 1
shows that 66 children tested negative for IGT at all four
annual visits and at the other extreme, only six children
tested positive at each annual visit. Similarly, 90 children
tested negative for IFG at all four annual visits, and only
one tested positive for IFG at each annual visit. Between
these two extremes there was tremendous variability in
the individual patterns of change in glucose status over the
4 years. This variation precluded the ability to ascertain
with any conﬁdence segments of the cohort that pro-
gressed from normal to pre-diabetes or reversed from
pre-diabetes over the 4 years. By deﬁning pre-diabetes as
the presence of either IFG or IGT, we characterized the
group as a function of the persistence of pre-diabetes over
4 years. Fifty-one children (40%) never had pre-diabetes at
any visit, 61 children (47%) had intermittent pre-diabetes,
and 16 children (13%) had persistent pre-diabetes over 4
years. The unadjusted baseline characteristics of these
three groups are shown in Table 2. Although those with
persistent pre-diabetes tended to be female and further
along in maturation, these differences were not signiﬁcant
in a 
2 analysis. Those with persistent pre-diabetes had
signiﬁcantly higher fasting and 2-h glucose, greater vis-
ceral fat, and poorer BCF at baseline (Table 2).
TABLE 1
Patterns of IGT and IFG across four consecutive annual visits in
122 overweight and obese Hispanic children
Positive or negative for IGT or IFG at
each of four visits Pattern
Visit 1 Visit 2 Visit 3 Visit 4 IGT IFG
  66 (51.6) 90 (70.3)
	  12 (9.4) 4 (3.1)
 	 5 (3.9) 1 (0.8)
 	 10 (7.8) 8 (6.3)
 	 6 (4.7) 7 (5.5)
	 	 2 (1.6) 1 (0.8)
	 	 1 (0.8) 0 (0)
 		 5 (3.9) 1 (0.8)
	 	 4 (3.1) 3 (2.3)
 		 4 (3.1) 4 (3.1)
 		 1 (0.8) 3 (2.3)
	 		 1 (0.8) 0 (0)
	 		 3 (2.3) 2 (1.6)
 			 2 (1.6) 3 (2.3)
	 			 6 (4.7) 1 (0.8)
Data are n (%).
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patterns of changes in key variables over time adjusting
for appropriate covariates (Table 3). Over the 3 years,
body weight increased by 20 kg, but the rate of increase
in body weight was similar in the three subgroups that
differed by pre-diabetes status (data not shown). BMI Z
score and BMI percentile were stable over time in the
group as a whole and in all subgroups. Also, the rate of
maturation (change in Tanner stage) was similar in all
subgroups (data not shown). Fat mass signiﬁcantly in-
creased over the 3 years, but fat mass and the change in fat
mass over time were not signiﬁcantly inﬂuenced by pre-
diabetes status. After adjusting for fat mass, SAAT did not
signiﬁcantly change over time, but there was a trend for
the interaction of time and IGT status (P  0.07) with
greater change observed in the groups with intermittent
and persistent pre-diabetes. Changes in IAAT over time
were signiﬁcantly associated with pre-diabetes status (P 
0.034 for the interaction of time and pre-diabetes status).
As shown in Table 3, IAAT signiﬁcantly increased in those
with persistent pre-diabetes and was relatively stable in
the other two groups. These effects remained signiﬁcant
even after including SAAT as an additional covariate in the
model.
Changes in metabolic parameters relating to type 2
diabetes (fasting and 2-h glucose, fasting insulin, Si, AIR,
and disposition index) are also shown in Table 3. Fasting
and 2-h glucose were signiﬁcantly higher in those with
persistent pre-diabetes but did not change over time in any
of the subgroups. Fasting insulin was not signiﬁcantly
inﬂuenced by persistence of pre-diabetes and did not
signiﬁcantly change over time. Si declined in all groups,
regardless of IGT status with a similar degree of decline in
all groups (Table 3). The AIR to glucose was signiﬁcantly
lower in the group with persistent pre-diabetes (P  0.01
for overall effect of pre-diabetes status; Table 3). As also
shown in Table 3, disposition index was signiﬁcantly lower
in those with persistent pre-diabetes (P  0.021), although
the changes over time were not signiﬁcantly inﬂuenced by
persistent pre-diabetes status.
DISCUSSION
In the current study, we report ﬁndings from a cohort of
128 overweight and obese Hispanic children at high risk of
developing type 2 diabetes evaluated annually for 4 years.
Our main ﬁndings are threefold. First, diagnosis of pre-
diabetes over time is highly variable from year to year,
making it very difﬁcult to identify systematic patterns of
change over time. The prevalence of persistent pre-diabe-
tes was 13%, lower than in prior cross-sectional reports
(15) but still alarmingly high. Second, we showed that in
the cohort as a whole, there was progressive deterioration
of Si, but those subjects with persistent pre-diabetes had a
lower BCF, explained by a lower than expected AIR for
the given degree of insulin resistance. Third, we found that
those children with persistent pre-diabetes had an increas-
ing visceral relative to subcutaneous abdominal fat accu-
mulation over time.
We are only aware of one other longitudinal study of
glucose tolerance status in children (20). In this study, 117
obese adolescents (84 with normal glucose tolerance and
33 with IGT) completed a follow-up OGTT 2 years later.
Fifteen subjects reverted to normal glucose tolerance, 10
had persistent IGT, and 8 subjects with IGT at baseline (7
African Americans, 1 Caucasian, and 0 Hispanics) devel-
oped type 2 diabetes. Severe obesity, IGT, and African
American ancestry predicted the development of type 2
diabetes (fasting glucose, insulin, and C-peptide were not
predictive). Outcomes were limited to parameters derived
from the OGTT and height and weight. These ﬁndings,
compared with our experience of no progression to type 2
diabetes in our Hispanic cohort, suggest the possibility of
an ethnic disparity in the natural history of the develop-
ment of pediatric type 2 diabetes, although analysis of
ethnic differences is limited by the underrepresentation of
Hispanics from the prior study (only four of the subjects
with IGT at baseline were Hispanic) and may be addition-
ally confounded by a much higher degree of adiposity at
baseline (per BMI criteria) in the prior study compared
with our cohort.
TABLE 2
Unadjusted baseline characteristics in the three groups based on patterns of the persistence of pre-diabetes over 4 years
Never Intermittent Persistent P value
Age (years) 10.9  1.9 11.0  1.7 11.9  1.6 NS
Sex (% girls) 51 38 63 NS
Tanner stage 2.3  1.3 1.9  1.2 2.8  1.7 0.051
Weight (kg) 63.0  19.7 63.0  19.3 72.0  21.2 NS
BMI percentile 96.6  4.2 97.4  2.8 97.0  3.7 NS
Waist (cm) 85.9  13.6 88.7  13.0 92.1  13.5 NS
Fat mass (kg) 24.3  10.3 24.7  10.3 29.0  11.7 NS
Fat-free mass (kg) 36.4  10.0 35.8  9.9 40.4  9.2 NS
IAAT (cm
2) 41.5  19.3 49.6  21.8 59.4  22.1 0.015
SAAT (cm
2) 325.0  159.3 319.6  120.1 409.4  141.9 0.1
Fasting glucose (mg/dl) 88.5  4.4 91.6  5.8 94.3  10.1 
0.001
Fasting insulin (U/ml) 18.4 	 12.7 19.5 	 10.7 22.6 	 10.9 NS
2-h glucose (mg/dl) 115.1  11.8 130.6  15.1 139.6  22.0 
0.001
Si (10
4 min
1  U
1  ml
1) 2.4  1.7 2.1  1.2 1.6  1.3 0.1
AIR (U/ml) 1,646  1,267 1,752  1,184 1,724  1,321 NS
Disposition index (10
4 min
1) 2,639  1,052 2,746  1,179 1,758  1,050 0.008
Sample size for age, sex, Tanner stage, weight, BMI percentile, fasting glucose and insulin, and 2-h glucose, n  128 (51 never, 61 intermittent,
and 16 persistent). Sample size for waist, fat mass, and lean mass, n  126 (50 never, 60 intermittent, and 16 persistent), Sample size for Si,
AIR, and disposition index, n  121 (48 never, 57 intermittent, and 16 persistent). Sample size for IAAT and SAT, n  109 (45 never, 50
intermittent, and 14 persistent).
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and obese Hispanic children of this cohort are extremely
insulin resistant. We have also previously shown that Si
deteriorated over 1 year, over and above that explained by
the accumulation of body fat (22). In the current study, we
extend these ﬁndings to show that the deterioration of Si is
progressive over 4 years. As shown in Table 3, the overall
effect of time on Si was highly signiﬁcant (P 
 0.01). Post
hoc analysis of the main effect of time showed a 31%
reduction in Si, independent of body fat over time (equiv-
alent to a drop of 0.23 Si units per year). The rate of decline
was not signiﬁcantly different according to pre-diabetes
status, although there was a hint of a greater decline in
those with pre-diabetes from years 2 to 4 (1.7  0.1 to 1.3
 0.1 10
4 min
1   U
1  ml
1). Where the groups did
differ was in the compensation to the progressive insulin
resistance. Those individuals with persistent pre-diabetes
showed a lower than expected AIR, corresponding to a
lower BCF (Table 3).
Although the overall effect of time on BCF was not
signiﬁcant in the repeated-measures ANOVA, post hoc
analysis suggested reductions over time regardless of
pre-diabetes status. By visit 4, the mean value of the
disposition index was signiﬁcantly lower than at visits 1
and 2 (2,405  147; 2,368  173; and 1972  134  10
4
min
1 at visits 1, 2, and 4, respectively; visit 4 was
signiﬁcantly different from visits 1 and 2; P 
 0.05). This
reduction in disposition index is equivalent to 136 dis-
position index units per year or a 6% decline in BCF per
year. This deterioration in BCF compares with a 10% per-
year decline in Hispanic women with prior GDM (23).
One of our major ﬁndings was a greater accumulation of
visceral adipose tissue over time, speciﬁcally in those
children with persistent pre-diabetes (Table 3). From the
current study, it is very difﬁcult to determine whether
persistent pre-diabetes caused the greater accumulation of
visceral adipose tissue or vice versa, but nevertheless, we
have shown that the two factors are strongly associated.
This ﬁnding suggests a possible hypothesis that persistent
hyperglycemia may lead to greater visceral fat accumula-
tion. In the current study, we were limited in our assess-
ment of visceral fat to a single-slice MRI. Further studies
TABLE 3
Repeated-measures ANOVA for the key outcome variables
Variables n
Baseline
(visit 1)
1-Year follow-up
(visit 2)
3-Year follow-up
(visit 4)
P value
Time
Pre-
diabetes
status
Interaction of
time and
pre-diabetes
Fat mass (kg)
Never 46 23.9  0.8 26.2  0.8 29.1  1.0
NS NS 0.08
Intermittent 58 24.7  0.6 27.3  0.7 30.0  0.9
Persistent 15 24.3  1.3 27.3  1.4 32.6  1.8
SAAT (cm
2)
Never 37 335  13 355  8 360  15
NS NS 0.07
Intermittent 40 317  12 361  8 402  14
Persistent 10 325  24 339  15 385  30
IAAT (cm
2)
Never 50 44.6  2.6 48.1  2.9 38.3  3.2
NS NS 0.034
Intermittent 31 49.7  2.9 46.3  2.9 40.2  3.1
Persistent 8 47.6  5.1 49.4  5.6 56.7  6.1
Fasting glucose (mg/dl) NS
Never 46 89  0.9 91  0.9 88  1.1
NS 
0.001
Intermittent 58 91  0.8 92  0.8 93  1.0
Persistent 15 94  1.6 97  1.6 95  1.9
Fasting insulin (U/ml)
Never 52 18.3 	 12.4 25.9 	 17.5 22.8 	 12.5
NS NS NS
Intermittent 36 20.9 	 12.0 22.9 	 12.5 25.7 	 11.6
Persistent 9 19.3 	 11.1 27.7 	 16.1 26.4 	 8.1
2-h glucose (mg/dl)
Never 46 114  2.1 115  2.1 108  2.9
0.03 
0.001 NS
Intermittent 58 131  1.9 132  2.0 127  2.5
Persistent 15 142  3.8 150  3.9 141  5.1
Si (10
4 min
1  U
1  ml
1)
Never 39 2.5  0.2 1.8  0.2 1.7  0.1

0.01 NS NS
Intermittent 45 2.2  0.2 1.8  0.1 1.7  0.1
Persistent 9 2.1  0.4 1.7  0.3 1.3  0.3
AIR (U/ml)
Never 1,714  150 2,198  164 1,709  103
NS 0.01 0.07
Intermittent 1,679  152 1,757  152 1,574  96
Persistent 1,146  316 922  346 1,007  218
Disposition index (10
4 min
1)
Never 39 2,667  177 2,864  209 2,182  161
NS 0.021 NS
Intermittent 45 2,759  164 2,543  195 2,226  150
Persistent 9 1,790  374 1,700  443 1,507  342
Data are the estimated marginal means adjusting for sex, baseline age, and Tanner and total fat mass at each of the measurement points. AIR
model also adjusts for Si. Fasting insulin data were log transformed. Fat mass model also adjusted for fat-free mass.
PRE-DIABETES IN HISPANIC CHILDREN
3010 DIABETES, VOL. 57, NOVEMBER 2008are needed to examine whether this association is linked
also to fat spillover into other organs, such as muscle and
liver. Fat deposition in the liver is associated with insulin
resistance and hyperinsulinemia in nonobese normal sub-
jects (24–26) and in obese subjects with type 2 diabetes
(26,27), and this seems to be independent of total body
adiposity. The time course and temporal patterns of these
effects are not clearly established, such that it is unknown
whether insulin resistance causes greater fat spillover or
vice versa (28). An alternative hypothesis explaining the
observed relationship between visceral adipose tissue and
pre-diabetes pattern might be that increased visceral fat
leads to increased release of free fatty acids into the portal
circulation. This could potentiate both insulin resistance
and the gradual loss of BCF, consistent with the portal
theory of insulin resistance and lipotoxicity as a proposed
cause of -cell failure (29). Future work should examine
whether persistent pre-diabetes and/or insulin resistance
is associated with liver fat accumulation and/or loss of
BCF due to lipotoxicity.
The variability in evaluation of IFG and IGT from year to
year could be either physiological ﬂuctuations over time or
measurement error. There is not much data on day-to-day
variation in fasting and 2-h glucose data during an OGTT in
children. We have conducted test-retest reliability in 23
overweight and obese Latino children (mean age 13.6 
1.6 years). The average time between repeated tests was
41.4  20.7 days (90% retested within 2 months). For
fasting glucose, the test-retest correlation was moderate
(r  0.52), and the within-subject coefﬁcient of variation
(CV) was 4.7%. For 2-h glucose, the test-retest correlation
was similar (r  0.52), but the within-subject CV was much
higher (16.2%). This poor reliability adds strength to the
justiﬁcation of basing diagnosis of pre-diabetes on more
than one oral glucose challenge test whether for research
or clinical purposes.
Two major limitations of this study should be pointed
out. The ﬁrst issue relates to the speciﬁc population in this
study (overweight Latino children and youth with a family
history of type 2 diabetes) and therefore limits generaliz-
ability of our ﬁndings to other groups. The second issue is
that the outcome of the current study was pre-diabetes,
not type 2 diabetes. The pattern of change in risk factors
over time may be different for type 2 diabetes compared
with pre-diabetes.
In conclusion, this detailed longitudinal cohort study
has shown that in overweight and obese Hispanic adoles-
cents with a family history of type 2 diabetes, the pattern
of pre-diabetes over time is highly variable from year to
year, but the prevalence of persistent pre-diabetes is
estimated to be 13%. Furthermore, we have shown that
persistent pre-diabetes is associated with compromised
BCF, a lower than expected AIR in response to progres-
sive insulin resistance, and a greater accumulation of
visceral fat over time. Thus, persistence of pre-diabetes,
rather than the ﬁnding of pre-diabetes at any single time
point, in addition to longitudinal accumulation of visceral
adipose tissue, may be more speciﬁc markers of future
diabetes risk.
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